Showing results (561-570 of 603) with videos related to
Sort By:
Pageof 61
Histopathology|September 1, 2019
Atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma in patients aged ≤ 40 years: a study of 116 patientsRebecca Waters, Andrew Horvai, Patricia Greipp, et al.JHEP Reports : Innovation in Hepatology|January 23, 2023
Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severityFrederik T Larsen, Daniel Hansen, Mike K Terkelsen, et al.Archives of Pathology & Laboratory Medicine|July 3, 2020
Histopathologic Assessment of Suspected Idiopathic Pulmonary Fibrosis: Where We Are and Where We Need to GoMaxwell L Smith, Lida P Hariri, Mari Mino-Kenudson, et al.Psychological Medicine|May 27, 2024
Shared familial risk for type 2 diabetes mellitus and psychiatric disorders: a nationwide multigenerational genetics studyTheresa Wimberley, Isabell Brikell, Aske Astrup, et al.British Journal of Haematology|June 13, 2022
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myelomaJithma P Abeykoon, Julia Vaxman, Sanjay V Patel, et al.Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.Annals of Diagnostic Pathology|May 28, 2019
Micropapillary adenocarcinoma of lung: Morphological criteria and diagnostic reproducibility among pulmonary pathologistsPaloma Del C Monroig-Bosque, Joel A Morales-Rosado, Anja C Roden, et al.The Lancet. Haematology|October 9, 2022
Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trialSagar Lonial, Rakesh Popat, Cyrille Hulin, et al.Human Reproduction (Oxford, England)|January 5, 2022
Developmental stage and morphology of the competent blastocyst are associated with sex of the child but not with other obstetric outcomes: a multicenter cohort studyM B Borgstrøm, U S Kesmodel, T W Klausen, et al.Nature Communications|July 12, 2019
Paternal-age-related de novo mutations and risk for five disordersJacob L Taylor, Jean-Christophe P G Debost, Sarah U Morton, et al.Pageof 61